Zimmer Biomet — Third Quarter 2026 Earnings Summary

Zimmer Biomet reported third-quarter 2026 net sales of $2.063 billion, representing a 3.1% increase on a reported basis and a 3.7% increase on a constant currency basis compared to the prior year. Diluted earnings per share for the quarter were $1.00, a 13.8% decrease from the previous year, while adjusted diluted earnings per share remained consistent at $1.90. The company generated $560.0 million in operating cash flow and $372.4 million in free cash flow during the period. Additionally, Zimmer Biomet updated its full-year 2026 financial guidance, raising the projected organic constant currency revenue growth range to 3.0%–3.5% and adjusted diluted earnings per share to $8.50–$8.60.